The Korea Food and Administration (KFDA) says new drug licenses in the first half of this year totaled 389 from 121 pharmaceutical firms, a whopping decrease of 45.3 percent over the same period of last year (712 items). Of the licenses, OTCs accounted for 212, prescription drugs for 155, and raw materials for 22.
By therapeutic category, antipyretics, analgesics & anti-inflammatory agents (...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.